Publikationen in Zusammenarbeit mit Forschern von Howard Hughes Medical Institute (3)

2020

  1. Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers

    Open Heart, Vol. 7, Núm. 1

2015

  1. Diltiazem treatment for pre-Clinical hypertrophic cardiomyopathy sarcomereMutation carriers: A pilot randomized trial to modify disease expression

    JACC: Heart Failure, Vol. 3, Núm. 2, pp. 180-188

2010

  1. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy

    New England Journal of Medicine, Vol. 363, Núm. 6, pp. 552-563